Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $185
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Johnson & Johnson and raises the price target from $180 to $185.
October 16, 2024 | 7:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch has maintained a Buy rating on Johnson & Johnson and increased the price target from $180 to $185, indicating a positive outlook.
The increase in the price target from $180 to $185 by Citigroup suggests a positive outlook for Johnson & Johnson, likely leading to a short-term positive impact on the stock price. The maintained Buy rating reinforces investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100